Posted in ace2 elisa, aflatoxin elisa, Antibodies, Assay Kits, Biology Cells, cDNA, Clia Kits, Culture Cells, Devices, DNA, DNA Templates, dylight 488, Elisa Kits, Enzymes, Equipments, Exosomes, fgf21 elisa, Gels, igf1 elisa, igf2 elisa kit, il3 elisa, Isotypes, mag antibody, Medium & Serums, NATtrol, Panel, Particles, PCR, Pcr Kits, Peptides, rat elisa kits, Reagents, Recombinant Proteins, research antibody, Ria Kits, RNA, Test Kits, Vector & Virus, Western Blot

Identification of low molecular weight degradation merchandise from chitin and chitosan

cd1234567890

Identification of low molecular weight degradation merchandise from chitin and chitosan by electrospray ionization time-of-flight mass spectrometry

The helpful results offered by chitosan oligosaccharides (COS) make them of curiosity in medical analysis.
The monomers that represent COS confer distinct properties, so controlling COS composition throughout their manufacturing is important.
On this work, we degraded chitin and chitosan polymers and recognized low molecular weight merchandise resembling COS that shaped, utilizing electrospray ionization time-of-flight mass spectrometry.
Our outcomes present that hydrochloric acid, hydrogen peroxide, and nitrous acid generate distinct merchandise from chitin and chitosan.
Hydrochloric acid degrades chitin and chitosan to provide glucosamine (GlcN) monomers and oligomers. Hydrogen peroxide degrades chitosan to provide GlcN and N-acetyl-d-glucosamine (GlcNAc) monomers and oligomers, and nitrous acid degrades chitosan to provide 2,5-anhydro- d-mannose.
Our research present that COS composition is dictated by each the degradation protocol and the beginning polymer. Moreover, our outcomes allow number of degradation protocols primarily based on their capacity to degrade chitin and chitosan and facilitate the manufacturing of COS with desired compositions.
Key phrases: Chitin; Chitosan; Mass spectrometry; Polysaccharide degradation.
cd1234567890
cd1234567890

Influenza A H3 Antibody
abx021978-1mg 1 mg
EUR 878

Lung Tissue Lysate (Tumor)
1703-07 0.1 mg
EUR 280.25
Description: Lung tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Kidney Tissue Lysate (Tumor)
1707-07 0.1 mg
EUR 280.25
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Normal)
1710-07 0.1 mg
EUR 217.25
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-07 0.1 mg
EUR 280.25
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Colon Tissue Lysate (Normal)
1715-07 0.1 mg
EUR 217.25
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide
11-563 0.05 mg
EUR 527
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide
11-564 0.05 mg
EUR 527
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza A antibody
10-1096 500 ug
EUR 208
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1097 1 mg
EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1098 1 mg
EUR 605
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1099 1 mg
EUR 605
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1100 500 ug
EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1101 1 mg
EUR 605
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1102 500 ug
EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1103 500 ug
EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1241 500 ug
EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-1243 500 ug
EUR 349
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-7866 1 mg
EUR 403
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-7867 1 mg
EUR 403
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50A 1 mg
EUR 503
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50B 1 mg
EUR 392
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50C 1 mg
EUR 392
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50D 1 mg
EUR 279
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50E 1 mg
EUR 279
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50F 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50G 1 mg
EUR 408
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50H 1 mg
EUR 541
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50I 1 mg
EUR 408
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50K 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50L 1 mg
EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50M 1 mg
EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50N 1 mg
EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50O 1 mg
EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50P 1 mg
EUR 300
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50Q 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50R 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50S 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50T 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10-I50U 1 mg
EUR 273
Description: Mouse monoclonal Influenza A antibody

Influenza A virus H3 PCR kit
PCR-H649-48R 50T
EUR 823

Influenza A virus H3 PCR kit
PCR-H649-96R 100T
EUR 1113

Influenza A Virus H3 Antigen Antibody
abx415738-01mg 0.1 mg
EUR 718

Influenza A virus fragment
A1075-10 10 mg
EUR 282
Description: Influenza A virus fragment has the RNA sequence of Leu-Lys-Phe-Ala-Phe-Ser-Met-Met.Influenzavirus A is agenusof the Orthomyxoviridaefamily of viruses.

IAV H3N2 nucleoprotein (A/Brisbane/10/2007) [His]
DAG2329 100 µg
EUR 724

Influenza B Virus Florida 07/04
7-07918 10µg Ask for price

Influenza B Virus Florida 07/04
7-07919 50µg Ask for price

Influenza B Virus Florida 07/04
7-07920 1mg Ask for price

Mouse Monoclonal Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG
H3N21-M 100 ul
EUR 482

Influenza A virus H3 RT PCR kit
RTq-H649-100R 100T
EUR 1311

Influenza A virus H3 RT PCR kit
RTq-H649-150R 150T
EUR 1787

Influenza A virus H3 RT PCR kit
RTq-H649-50R 50T
EUR 963

Influenza A HA H1 antibody
10-7839 500 ug
EUR 291
Description: Mouse monoclonal Influenza A haemagglutinin H1 antibody

Influenza A HA H1 antibody
10-7840 500 ug
EUR 291
Description: Mouse monoclonal Influenza A haemagglutinin H1 antibody

Influenza A HA H5 antibody
10-7854 1 mg
EUR 732
Description: Mouse monoclonal Influenza A HA H5 antibody

Influenza A HA H5 antibody
10-7855 1 mg
EUR 732
Description: Mouse monoclonal Influenza A HA H5 antibody

Influenza A HA H5 antibody
10-7856 1 mg
EUR 732
Description: Mouse monoclonal Influenza A HA H5 antibody

Influenza B (B / Florida / 07 / 04) Protein
abx060630-1mg 1 mg
EUR 1873

Influenza B Virus Florida 07 / 04 Protein
20-abx260511
  • EUR 230.00
  • EUR 2569.00
  • EUR 328.00
  • 10 ug
  • 1 mg
  • 50 ug

Influenza A virus H3 One-Step PCR kit
Oneq-H649-100R 100T
EUR 1610

Influenza A virus H3 One-Step PCR kit
Oneq-H649-150R 150T
EUR 2205

Influenza A virus H3 One-Step PCR kit
Oneq-H649-50R 50T
EUR 1175

IAV H3N2 H3 (aa 17-529) (A/Panama/07/99) [His]
DAG2162 100 µg Ask for price

hemagglutinin (332-340) [Influenza A virus]
A1141-10 10 mg
EUR 340
Description: Influenza hemagglutinin (HA) is a type of hemagglutinin found on the surface of the influenza viruses. It is an antigenic glycoprotein. It is responsible for binding the virus to the cell that is being infected.

IAV H3N2 (aa 18-530) (A/Brisbane/10/2007) [His]
DAG1693 50 ug
EUR 1681

IAV H3N2 non-structural 1 (A/Brisbane/10/2007 ) [His]
DAG2335 100 µg
EUR 724

Recombinant (HEK) Influenza A HA1 protein (A/California/07/2009 (H1N1; 18-345 aa,55-60 kda, >95%, his-tag)
H1N1-02-R-10 10 ug
EUR 286

Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-10ug
QP12081-10ug 10ug
EUR 155

Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-1mg
QP12081-1mg 1mg
EUR 2059

Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-50ug
QP12081-50ug 50ug
EUR 201

Influenza B Strain B/Florida/07/04 Antigen
11-575 0.1 mg
EUR 527
Description: Influenza B (B/Florida/07/04), Influenza B Virus, Strain B/Florida/07/04

Anti-07/02/07
STJ501223 100 µg
EUR 476

NATtrol Influenza A H3 Virus Stock (Qualitative) (1 mL)
NATFLUAH3-ST 1 mL
EUR 1137.84
Description: Please contact Gentaur in order to receive the datasheet of the product.

IAV H3N2 Hemagglutinin (aa 17-530) (A/Brisbane/10/2007) [His]
DAG2224 100 µg
EUR 913

IAV H1N1 nucleoprotein (aa 1-486) (A/Brisbane/10/2007) [His]
DAG2328 100 µg
EUR 724

Recombinant (HEK) Influenza A H1N1 HA protein (A/California/07/2009 (H1N1), ?TM 18-529 aa, 70-75 kda, >95%, his-tag)
H1N1-03-R-10 10 ug
EUR 286

[bAla8]-Neurokinin A(4-10)
B6813-10 10 mg
EUR 1479

A-20 Lysate
1288 0.1 mg
EUR 191
Description: A-20 lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The A-20 lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT.

hemagglutinin precursor (114-122) amide [Influenza A virus]
A1142-10 10 mg
EUR 340
Description: hemagglutinin precursor(114-122) amide [Influenza A virus]

IAV H3N2 Hemagglutinin 1 (aa 17-345) (A/Brisbane/10/2007) [His]
DAG2282 100 µg
EUR 913

Influenza A antibody
10R-I131a 1 mg
EUR 476
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10R-I131b 1 mg
EUR 489
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10C-CR1306M1 100 ug
EUR 506
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
10C-CR1306M2 100 ug
EUR 281
Description: Mouse monoclonal Influenza A antibody

Influenza A antibody
70R-IR080 100 ug
EUR 349
Description: Affinity purified Rabbit polyclonal Influenza A antibody

Influenza A antibody
70R-IR082 100 ug
EUR 300
Description: Affinity purified Rabbit polyclonal Influenza A antibody

Influenza A protein
30-1002 100 ug
EUR 349
Description: Recombinant Influenza A protein (NP antigen)

Influenza A protein
30-1303 1 mg
EUR 241
Description: Purified native Influenza A protein

Influenza A protein
30-1304 1 mg
EUR 295
Description: Purified native Influenza A protein

Influenza A protein
30-1305 1 mg
EUR 295
Description: Purified native Influenza A protein

Influenza A protein
30-1306 1 ml
EUR 295
Description: Purified native Influenza A protein

Influenza A protein
30-AI50 1 ml
EUR 262
Description: Purified Influenza A protein (H1N1 strain)

Influenza A protein
30-AI60 1 ml
EUR 262
Description: Purified Influenza A protein (H3N2 strain)

Rabbit Anti-Influenza A virus HA IgG (aff pure)
AB-23091-A 100ug
EUR 482

Molecular docking and dynamics simulations research of OmpATb identifies 4 potential novel pure product-derived anti-Mycobacterium tuberculosis compounds

The outer membrane protein A (OmpATb) of Mycobacterium tuberculosis is a virulence issue that neutralizes the host pH to impede the uptake of hydrophilic antitubercular medicine.
Figuring out pure compounds with the potential to inhibit OmpATb might permit circumvention of the porin-like actions of OmpATb. 4 potential leads comprising ZINC000003958185, ZINC000000157405, ZINC000000001392 and ZINC000034268676 had been obtained by digital screening of 6394 various pure merchandise.
Characterization of the binding interactions of the potential leads with OmpATb revealed 9 essential residues comprising ARG86, LEU110, LEU113, LEU114, ALA115, PHE142, SER145, VAL146, and PHE151. Molecular dynamics simulations additionally revealed very secure protein-lead complexes.
Most residues contributed decrease binding energies to the general molecular mechanics Poisson-Boltzmann floor space (MM-PBSA) binding free energies of the interactions between the molecules and OmpATb protein.
Induced Match Docking (IFD) of the compounds regenerated poses of the molecular docking utilizing AutoDock Vina. These molecules might be beginning templates for designing inhibitors to bypass the pore mediating actions of OmpATb.
Based mostly on structural similarity, ZINC000034268676 was urged as a possible scaffold for designing efflux pump inhibitors of the gate mediating actions of OmpATb and should improve the uptake of hydrophilic medicine to scale back the length time of tuberculosis therapy.
Moreover, structurally comparable compounds obtainable within the DrugBank database with a similarity threshold of 0.7 have been reported to exhibit antitubercular and anti-mycobacterial actions.
These biomolecules may be additional characterised experimentally to corroborate their antitubercular exercise. Additionally, the skeletons of the molecules may be adopted as sub-structures for the design of future anti-mycobacterial medicine.
Key phrases: Antitubercular compounds; Induced-fit docking; MM-PBSA; Molecular docking; Molecular dynamics; Mycobacterium tuberculosis OmpATb; Pure merchandise; Digital screening.

Probing the Molecular-Stage Interactions in an Energetic Pharmaceutical Ingredient (API) – Polymer Dispersion and the Ensuing Affect on Drug Product Formulation.

An investigation of underlying mechanisms of API-polymer interplay patterns has the potential to offer helpful insights for choosing applicable formulations with superior bodily stability and processability.
On this examine, copovidone was used as a polymeric provider for a number of mannequin compounds together with clotrimazole, nifedipine, and posaconazole.
The various chemical constructions conferred the power for the mannequin compounds to type distinct interactions with copovidone. Rheology and nuclear magnetic resonance (NMR) had been mixed to research the molecular sample and relative power of energetic pharmaceutical ingredient (API)-polymer interactions.
As well as, the affect of the interactions on formulation processability by way of sizzling soften extrusion (HME) and bodily stability had been evaluated.The rheological response of an API-polymer system was discovered to be extremely delicate to API-polymer interplay, relying each on API chemistry and API-polymer miscibility.
Within the techniques studied, dispersed API induced a stronger plasticizer impact on the polymer matrix in comparison with crystalline/aggregated API.
Correspondingly, the processing torque by way of HME confirmed a proportional relationship with the utmost advanced viscosity of the API-polymer system. To be able to quantitatively consider the relative power of the API-polymer interplay, homogeneously dispersed API-polymer amorphous samples had been ready by HME at an elevated temperature. DSC, XRD, and rheology had been employed to verify the amorphous integrity and homogeneity of the resultant extrudates.
Subsequently, the homogeneously dispersed API-polymer amorphous dispersions had been interrogated by rheology and NMR to offer a qualitative and quantitative evaluation of the character of the API-polymer interplay, each macroscopically and microscopically.
Rheological grasp curves of frequency sweeps of the extrudates exhibited a powerful dependence on the API chemistry and revealed a rank ordering of the relative power of API-copovidone interactions, within the order of posaconazole > nifedipine > clotrimazole.
NMR knowledge offered the means to exactly map the API-polymer interplay sample and determine the particular websites of interplay from a molecular perspective. Lastly, the affect of API-polymer interactions on the bodily stability of the resultant extrudates was studied.
Qualitative and quantitative analysis of the relative power of the API-polymer interplay was efficiently achieved by using mixed rheology and NMR. Graphical Summary.

Anti-Galectin 1 Antibody
A00470-2 100ug/vial
EUR 294

Anti-Galectin-1 antibody
STJ98716 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-1.

Anti-Galectin-1 antibody
STJ93201 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-1.

anti- Galectin-1 antibody
FNab03314 100µg
EUR 505.25
Description: Antibody raised against Galectin-1

anti- Galectin-1 antibody
FNab03315 100µg
EUR 548.75
Description: Antibody raised against Galectin-1

Anti-Galectin-1 antibody
PAab03314 100 ug
EUR 355

Anti-Galectin 1 (1A8)
YF-MA13984 100 ug
EUR 363
Description: Mouse monoclonal to Galectin 1

Anti-Galectin 1/LGALS1 Antibody
PA1422 100ug/vial
EUR 334

Anti-Galectin 1/LGALS1 Antibody
PB9240 100ug/vial
EUR 334

Anti-Galectin 1/Lgals1 Antibody
A00470 100ug/vial
EUR 334

Anti-Galectin 1 Biotinylated Antibody
A00470-Biotin 50ug/vial
EUR 294

Anti-galectin-1 (mouse) antibody
STJ72519 100 µg
EUR 359

anti-Galectin 1 (1E8-1B2)
LF-MA10174 100 ug
EUR 363
Description: Mouse monoclonal to Galectin 1

Anti-Galectin-13 (GAL13) / Placental Protein 13 (PP13) Monoclonal Antibody
M08143-1 100ug/vial
EUR 397
Description: Mouse Monoclonal Galectin-13 (GAL13) / Placental Protein 13 (PP13) Antibody. Validated in IHC and tested in Human.

Polyclonal Goat anti-GST μ-form
GST-ANTI-2 50 uL
EUR 280

Polyclonal Goat anti-GST p-form
GST-ANTI-3 50 uL
EUR 280

anti-Galectin 3
YF-PA12946 50 ug
EUR 363
Description: Mouse polyclonal to Galectin 3

anti-Galectin 3
YF-PA12947 100 ul
EUR 403
Description: Rabbit polyclonal to Galectin 3

anti-Galectin 3
YF-PA12948 100 ug
EUR 403
Description: Rabbit polyclonal to Galectin 3

anti-Galectin 8
YF-PA12951 50 ul
EUR 363
Description: Mouse polyclonal to Galectin 8

anti-Galectin 3
YF-PA24079 50 ul
EUR 334
Description: Mouse polyclonal to Galectin 3

anti-galectin 9
YF-PA24081 50 ul
EUR 334
Description: Mouse polyclonal to galectin 9

anti-Galectin 13
YF-PA18585 50 ug
EUR 363
Description: Mouse polyclonal to Galectin 13

Anti-human Galectin-3 antibody
STJ15100163 250 µg
EUR 336
Description: This monoclonal antibody is for studies of antigen expression in cells and tissue sections using immunocytochemistry and immunoprecipitation

LGALS7 Human, Galectin-7 Human Recombinant Protein, His Tag
PROTP47929-1 Regular: 20ug
EUR 317
Description: Galectin-7 Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 156 amino acids (1-136 a.a.) and having a molecular mass of 17.2kDa. ;The Galectin-7 is purified by proprietary chromatographic techniques.

LGALS3 Human, Galectin-3 Human Recombinant Protein, His Tag
PROTP17931-1 Regular: 25ug
EUR 317
Description: LGALS3 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 270 amino acids (1-250 a.a.) and having a molecular mass of 28.3 kDa._x000D_ The LGALS3 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques. _x000D_

LGALS8 Human, Galectin-8 Human Recombinant Protein, His Tag
PROTO00214-1 Regular: 10ug
EUR 317
Description: LGALS8 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 337 amino acids (1-317 a.a.) and having a molecular mass of 37.9 kDa. The LGALS8 is fused to a 20 amino acid His-Tag at N-terminus and purified by proprietary chromatographic techniques.

Human Galectin-3 (Gal-3) AssayMax ELISA Kit
EG3311-1 96 Well Plate
EUR 477

Human Galectin-4 (Gal-4) AssayMax ELISA Kit
EG3312-1 96 Well Plate
EUR 477

Human Galectin-1 (LGALS1)
1-CSB-EP012882HU
  • EUR 380.00
  • EUR 214.00
  • EUR 1309.00
  • EUR 560.00
  • EUR 873.00
  • EUR 262.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

Human Galectin-1 (LGALS1)
1-CSB-EP012882HUb1
  • EUR 380.00
  • EUR 214.00
  • EUR 1309.00
  • EUR 560.00
  • EUR 873.00
  • EUR 262.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

Human Galectin 1 Protein
20-abx066725
  • EUR 620.00
  • EUR 272.00
  • EUR 1859.00
  • EUR 732.00
  • EUR 453.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Recombinant Human Galectin-1
7-00427 10µg Ask for price

Recombinant Human Galectin-1
7-00428 50µg Ask for price

Recombinant Human Galectin-1
7-00429 1mg Ask for price

Galectin-1, human recombinant
4648-10
EUR 142

Galectin-1, human recombinant
4648-1000
EUR 1648

Galectin-1, human recombinant
4648-50
EUR 262

Anti-Galectin-3 antibody
STJ16100369 1 mL
EUR 1047

Anti-Galectin-3 antibody
STJ16100782 100 µg
EUR 720

Anti-Galectin-3 antibody
STJ180106 0.1 ml
EUR 212

Anti-Galectin 3 antibody
STJ190057 200 µl
EUR 197
Description: Unconjugated Mouse monoclonal to Galectin 3 (AS1A24)

Anti-Galectin-9 Antibody
A03415 100ul
EUR 397
Description: Rabbit Polyclonal Antibody for Galectin-9 Antibody (LGALS9) detection.tested for WB in Human, Mouse, Rat.

Anti-Galectin-3 antibody
STJ96945 200 µl
EUR 197
Description: Galectin-3 is a protein encoded by the LGALS3 gene which is approximately 26,1 kDa. Galectin-3 is localised to the cytoplasm and nucleus. It is involved in NF-kappaB signalling, advanced glycosylation end product receptor signalling and cell adhesion. It is a galactose-specific lectin which binds IgE and may mediate the stimulation by CSPG4 of endothelial cells migration along with the alpha-3, beta-1 integrin. It is characterized by an N-terminal proline-rich tandem repeat domain and a single C-terminal carbohydrate recognition domain. Galectin-3 is expressed mainly in the colonic epithelium and is also abundantly expressed in activated macrophages. Mutations in the LGALS3 gene may result in follicular adenoma and thyroid cancer. STJ96945 was developed from clone 6G2 and was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen. This antibody detects endogenous galectin-3 proteins.

Anti-Galectin-3 antibody
STJ97549 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3 (6B8).

Anti-Galectin-3 antibody
STJ97550 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3 (8D7).

Anti-Galectin-3 antibody
STJ97551 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3 (5D9).

Anti-Galectin-3 antibody
STJ97601 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3 (2F9).

Anti-Galectin-3 antibody
STJ97604 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3 (16E6).

Anti-Galectin-3 antibody
STJ97605 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3 (1H4).

Anti-Galectin-3 antibody
STJ97715 200 µl
EUR 197
Description: Mouse monoclonal to Galectin-3.

Anti-Galectin-2 antibody
STJ93202 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-2.

Anti-Galectin-4 antibody
STJ93203 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-4.

Anti-Galectin-7 antibody
STJ93204 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-7.

Anti-Galectin-8 antibody
STJ93205 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-8.

Anti-Galectin-9 antibody
STJ93206 200 µl
EUR 197
Description: Rabbit polyclonal to Galectin-9.

Anti-Galectin 3 antibody
STJ73098 100 µg
EUR 359

anti- Galectin 2 antibody
FNab03310 100µg
EUR 585
Description: Antibody raised against Galectin 2

anti- Galectin 4 antibody
FNab03311 100µg
EUR 505.25
Description: Antibody raised against Galectin 4

anti- Galectin 8 antibody
FNab03312 100µg
EUR 505.25
Description: Antibody raised against Galectin 8

anti- Galectin 9 antibody
FNab03313 100µg
EUR 505.25
Description: Antibody raised against Galectin 9

anti- Galectin-3 antibody
FNab03316 100µg
EUR 505.25
Description: Antibody raised against Galectin-3

anti- Galectin-3 antibody
FNab03317 100µg
EUR 548.75
Description: Antibody raised against Galectin-3

anti- Galectin-7 antibody
FNab03318 100µg
EUR 505.25
Description: Antibody raised against Galectin-7

anti-Galectin-3 (6G2)
LF-MA20336 100 ug
EUR 354
Description: Mouse monoclonal to Galectin-3

Anti-Galectin 2 antibody
PAab03310 100 ug
EUR 412

Anti-Galectin 4 antibody
PAab03311 100 ug
EUR 355

Anti-Galectin 8 antibody
PAab03312 100 ug
EUR 355

Anti-Galectin 9 antibody
PAab03313 100 ug
EUR 355

Anti-Galectin-3 antibody
PAab03316 100 ug
EUR 355

Anti-Galectin-7 antibody
PAab03318 100 ug
EUR 355

Anti-Galectin 8 (3E5)
YF-MA13986 100 ug
EUR 363
Description: Mouse monoclonal to Galectin 8

Anti-galectin-1 (mouse) (aa100-112) antibody
STJ72520 100 µg
EUR 359

Anti Human Galectin-3 Polyclonal Antibody
KH040
EUR 649
Description: The Anti Human Galectin-3 Polyclonal Antibody is available in Europe and for worldwide shipping via Gentaur.

Anti-Galectin-1 / Human Placental Lactogen (hPL) Monoclonal Antibody
M00470 100ug/vial
EUR 397
Description: Mouse Monoclonal Galectin-1 / Human Placental Lactogen (hPL) Antibody. Validated in IHC and tested in Human.

Galectin-1 (LGAS1)
PR27143 50 ug
EUR 318

Galectin 1 Antibody
49673-100ul 100ul
EUR 333

Galectin 1 Antibody
49673-50ul 50ul
EUR 239

Galectin-1 Protein
20-abx261634
  • EUR 3418.00
  • EUR 328.00
  • EUR 230.00
  • 1 mg
  • 20 ug
  • 5 ug

Galectin-1 Protein
20-abx263505
  • EUR 230.00
  • EUR 1790.00
  • EUR 328.00
  • 10 ug
  • 1 mg
  • 50 ug

rHu Galectin-1
AK8281-0010 10µg Ask for price

rHu Galectin-1
AK8281-0050 50µg Ask for price

rHu Galectin-1
AK8281-0100 100µg Ask for price

rHu Galectin-1
AK8281-1000 1mg Ask for price

Galectin 1 antibody
70R-11939 100 ug
EUR 403
Description: Rabbit polyclonal Galectin 1 antibody

Galectin 1 antibody
70R-13963 100 ug
EUR 322
Description: Affinity purified Rabbit polyclonal Galectin 1 antibody

Galectin 1 antibody
70R-49997 100 ul
EUR 244
Description: Purified Polyclonal Galectin 1 antibody

Galectin 1 antibody
70R-GR002 100 ug
EUR 476
Description: Affinity purified Rabbit polyclonal Galectin 1 antibody

Galectin 1 protein
30R-1385 100 ug
EUR 224
Description: Purified recombinant Human Galectin 1 protein

Omar

Leave A Comment

October 2022
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31